Internal Medicine, Hematology & Oncology · Wichita, KS
NPI
1558323758
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3243 E Murdock St Ste 300
Wichita, KS, 67208
Phone (316) 262-4467
Groups this clinician bills Medicare through
Medicare paid, 2024
$8.1M
477,106 services
Medicare patients, 2024
1,175
Average age 75
Drug cost, 2024
$6.7M
3,677 prescriptions
Company payments, 2025
$15K
From 60 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Phu V Truong was code Q5110 (injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram), 50,460 times for 35 patients. In total Phu V Truong billed 477,106 services in 219 codes, and Medicare paid $8.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-02.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 50,460 | 35 | $0.21 | $11K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 39,695 | 38 | $2.31 | $92K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 34,000 | 49 | $44.51 | $1.5M |
| J0185 Injection, aprepitant, 1 mg | Office | 32,370 | 93 | $1.35 | $44K |
| J9299 Injection, nivolumab, 1 mg | Office | 28,220 | 22 | $24.63 | $695K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 21,500 | 24 | $0.05 | $1,148 |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 20,250 | 19 | $0.87 | $18K |
| J1627 Injection, granisetron, extended-release, 0.1 mg | Office | 19,500 | 77 | $4.40 | $86K |
| J0897 Injection, denosumab, 1 mg | Office | 16,680 | 105 | $20.49 | $342K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 15,048 | 50 | $20.90 | $315K |
| J9267 Injection, paclitaxel, 1 mg | Office | 13,296 | 23 | $0.08 | $1,073 |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 8,670 | 12 | $0.22 | $1,935 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 6,660 | 13 | $39.34 | $262K |
| Q5129 Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg | Office | 5,580 | 23 | $49.52 | $276K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,690 | 163 | $0.09 | $421 |
By year: 2022 $6.0M for 422,774 services; 2023 $7.8M for 509,789 services; 2024 $8.1M for 477,106 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,717 | 355 | $8.65 | $15K |
| 85027 Blood Count | 1,606 | 355 | $6.34 | $10K |
| 85007 Blood Count | 1,603 | 354 | $3.72 | $5,963 |
| 80053 Clinical Chemistry | 1,268 | 344 | $10.35 | $13K |
| 84443 Clinical Chemistry | 193 | 69 | $16.46 | $3,177 |
| 84439 Clinical Chemistry | 191 | 68 | $8.84 | $1,688 |
| 82728 Clinical Chemistry | 175 | 98 | $13.36 | $2,338 |
| 83540 Clinical Chemistry | 173 | 98 | $6.34 | $1,097 |
| 83550 Clinical Chemistry | 173 | 98 | $8.57 | $1,483 |
| 83615 Clinical Chemistry | 161 | 103 | $5.92 | $953 |
Medicare prescription drug claims, 2024
In 2024, the drug Phu V Truong prescribed most often to Medicare patients was Anastrozole, with 540 prescriptions and refills. In total Phu V Truong wrote 3,677 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 540 | 987 | 108 | $5,841 |
| Ondansetron Hcl Generic | 174 | 174 | 78 | $1,367 |
| Gabapentin Generic | 154 | 176 | 26 | $1,908 |
| Dexamethasone Generic | 120 | 149 | 39 | $1,437 |
| Levothyroxine Sodium Generic | 119 | 213 | 26 | $673 |
| Tamoxifen Citrate Generic | 110 | 189 | 22 | $1,781 |
| Potassium Chloride Generic | 104 | 162 | 33 | $1,180 |
| Prednisone Generic | 101 | 121 | 36 | $471 |
| Acyclovir Generic | 90 | 115 | 19 | $1,313 |
| Ondansetron Odt Ondansetron | 77 | 77 | 33 | $860 |
| Alendronate Sodium Generic | 73 | 151 | 20 | $270 |
| Hydroxyurea Generic | 71 | 142 | 17 | $1,495 |
| Prochlorperazine Maleate Generic | 69 | 69 | 29 | $1,005 |
| Levofloxacin Generic | 69 | 69 | 42 | $286 |
| Xtandi Enzalutamide | 66 | 66 | Under 11 | $882K |
Brand drugs: 652 claims; generic drugs: 3,025 claims; opioid claims: 94.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Phu V Truong $15K ($15K in general payments such as food, travel and fees) from 60 companies. The largest payer was Gilead Sciences, Inc. with $4,670.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 17 | $4,670 |
| Syndax Pharmaceuticals, Inc. SNDX | 9 | $4,426 |
| Novartis Pharmaceuticals Corporation NVS | 28 | $530 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $523 |
| Aveo Pharmaceuticals, Inc. | 7 | $347 |
| Merck Sharp & Dohme LLC MRK | 10 | $287 |
| Pfizer Inc. PFE | 25 | $283 |
| Eisai Inc. 4523.T | 14 | $243 |
| E.R. Squibb & Sons, L.L.C. BMY | 19 | $233 |
| Abbvie Inc. ABBV | 17 | $221 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.